FILTER

Refine your search with the following facets to narrow down your results.

5 Current news of bitop

bitop AG receives Frost & Sullivan’s 2013 New Product Innovation Award for its Ectoin Allergy products

24-Jun-2013 - Frost & Sullivan grants the 2013 European New Product Innovation Award in Extremolytes Therapeutics to bitop AG. The benchmark by Frost & Sullivan indicates that bitop AG has made available Ectoin, one of the most commonly found extremolytes in nature, for human use. bitop AG has explored and ...

allergies ectoin Frost & Sullivan

Ectoine: a natural compound reduces lung inflammation

22-Feb-2013 - Scientists from the IUF Leibniz Research Institute for Environmental Medicine in Düsseldorf show that the extremolyte Ectoin® may positively influence lung inflammation associated with chronic obstructive pulmonary disease (COPD). From earlier studies it was known that Ectoin has the potential to ...

allergic rhinitis asthma atopic dermatitis +2

Bitop Announces Start of Clinical Trial with Ectoin Inhalation Solution in Patients with Inflammation and Obstruction of Airways

08-Nov-2010 - bitop AG announced the inclusion of the first patient into a clinical trial on the Ectoin inhalation solution in patients with inflammation and airway obstruction. The present clinical study is a single-center efficacy and feasibility study involving patients with inflammation and airway ...

ageing allergic rhinitis asthma +7

Bitop AG Reports That Ectoin Reduces Symptoms of Acute Allergic Rhinitis

14-Jul-2010 - bitop AG reports that Ectoin allergy nasal spray has been shown to significantly reduce symptoms of acute allergic rhinitis in a two-week observational, randomized, comparative crossover study with 50 patients suffering from acute allergic rhinitis. Based on this study, bitop performed a clinical ...

allergic rhinitis allergies clinical trials +1

bitop AG and Activaero collaborate on clinical study of inhalable Ectoin-solution

19-Jun-2009 - bitop AG and Activaero GmbH announced the start of a clinical study on bitop AG’s medical device Ectoin® inhalation solution using Activaero’s controlled breathing technology, the AKITA² inhalation system. Ectoin® inhalation solution is based on Ectoin®, an extremolyte, a natural substance ...

dosing ectoin Germany +2